The Cardiovascular Research Foundation(CRF) is a 501(c)3 not-for-profit organization, governed by a Board of Directors whose members include officers of the foundation, professional advisors, and distinguished advocates and leaders in the field of cardiovascular medicine.
Eric B. Woldenberg, Esq. is Chairman of the Board of Directors of the Cardiovascular Research Foundation. He has been a Partner at Pryor Cashman since 1988, specializes in taxation and estate planning and serves as Chairman of the firm's Tax Group.
William A. Himmelsbach, MPH, FACHE is President and Chief Executive Officer of the Cardiovascular Research Foundation. Prior to joining CRF, he was Senior Vice President of VHA and Executive Officer of its New York-based VHA Empire - Metro.
Joseph G. Beck is a principal with Shattuck Hammond partners.
Colette Y. Gardner is Managing Director for the international business unit of Mitsubishi UFJ Securities, a leading global financial services firm, and a specialist in Human Resources. She has extensive experience with several leading financial firms over the past 20 years.
Jeffrey W. Moses, MD is Professor of Clinical Medicine and Director of the Center for Interventional Vascular Therapy at Columbia University Medical Center. He also serves as Director of the Cardiac Catherization Lab at NewYork-Presbyterian Hospital/CUMC.
Arthur J. Pergament is the Founder and Chief Executive Officer of Pergament Advisors, LLC, a wealth management firm specializing in the institutional and high net worth communities.
Eric A. Rose, MD is Executive Vice President for Life Sciences at MacAndrews and Forbes Holidings, Inc., and CEO of SIGA Technologies, Inc. Dr. Rose is also Chairman of the Department of Health Policy at Mount Sinai School of Medicine.
Marvin L. Woodall, was President of Johnson & Johnson Interventional Systems Company (JJIS) from 1988 until 1996, during a critical era for the interventional cardiology field. He was instrumental in pioneering the development of two stents: the Palmaz-Schatz coronary stent, which was the world’s first major balloon-expandable stent, and the Cypher drug-eluting stent. Mr. Woodall became an active member of CRF’s Board in 2000.
